Michael A. Metzger
2021
In 2021, Michael A. Metzger earned a total compensation of $3.3M as Chief Operating Officer at Syndax Pharmaceuticals, a 71% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $297,050 |
|---|---|
| Option Awards | $2,434,751 |
| Salary | $594,104 |
| Other | $8,000 |
| Total | $3,333,905 |
Metzger received $2.4M in option awards, accounting for 73% of the total pay in 2021.
Metzger also received $297.1K in non-equity incentive plan, $594.1K in salary and $8K in other compensation.
Rankings
In 2021, Michael A. Metzger's compensation ranked 4,007th out of 12,406 executives tracked by ExecPay. In other words, Metzger earned more than 67.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,007 out of 12,406 | 68th |
Division Manufacturing | 1,640 out of 5,494 | 70th |
Major group Chemicals And Allied Products | 678 out of 2,369 | 71st |
Industry group Drugs | 602 out of 2,090 | 71st |
Industry Pharmaceutical Preparations | 421 out of 1,537 | 73rd |
Source: SEC filing on March 29, 2022.
Metzger's colleagues
We found three more compensation records of executives who worked with Michael A. Metzger at Syndax Pharmaceuticals in 2021.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019